FDA
-
-
-
-
-
-
-
Cyclerion Announces Reverse Stock Split
-
-
-
-
-
-
-
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Cyclerion Therapeutics (CYCN) Announces CY6463 Pipeline Progress; Reports Q2
-
-
-
-
-
-
-
Cyclerion Therapeutics (CYCN) Provides Additional Positive CY6463 MELAS Data
-
-
-
-
-
-
-
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium
-
-
-
-
-
-
-
Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
-
-
-
-
-
-
-
Cyclerion Updates Corporate Progress
-
322,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

